Your browser doesn't support javascript.
loading
Genetic factors affecting storage and utilization of lipids during dormancy in Mycobacterium tuberculosis.
Sturm, Alexander; Sun, Penny; Avila-Pacheco, Julian; Clatworthy, Anne E; Bloom-Ackermann, Zohar; Wuo, Michael G; Gomez, James E; Jin, Soomin; Clish, Clary B; Kiessling, Laura L; Hung, Deborah T.
Afiliação
  • Sturm A; Infectious Disease and Microbiome Program, Broad Institute, Cambridge, Massachusetts, USA.
  • Sun P; Department of Molecular Biology and Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Avila-Pacheco J; Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
  • Clatworthy AE; Infectious Disease and Microbiome Program, Broad Institute, Cambridge, Massachusetts, USA.
  • Bloom-Ackermann Z; Metabolomics Platform, Broad Institute, Cambridge, Massachusetts, USA.
  • Wuo MG; Infectious Disease and Microbiome Program, Broad Institute, Cambridge, Massachusetts, USA.
  • Gomez JE; Department of Molecular Biology and Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Jin S; Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
  • Clish CB; Infectious Disease and Microbiome Program, Broad Institute, Cambridge, Massachusetts, USA.
  • Kiessling LL; Department of Molecular Biology and Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Hung DT; Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.
mBio ; 15(2): e0320823, 2024 Feb 14.
Article em En | MEDLINE | ID: mdl-38236034
ABSTRACT
Mycobacterium tuberculosis (Mtb) can adopt a non-growing dormant state during infection that may be critical to both active and latent tuberculosis. During dormancy, Mtb is widely tolerant toward antibiotics, a significant obstacle in current anti-tubercular drug regimens, and retains the ability to persist in its environment. We aimed to identify novel mechanisms that permit Mtb to survive dormancy in an in vitro carbon starvation model using transposon insertion sequencing and gene expression analysis. We identified a previously uncharacterized component of the lipid transport machinery, omamC, which was upregulated and required for survival during carbon starvation. We show that OmamC plays a role both in increasing fatty acid stores during growth in rich media and enhancing fatty acid utilization during starvation. Besides its involvement in lipid metabolism, OmamC levels affected the expression of the anti-anti-sigma factor rv0516c and other genes to improve Mtb survival during carbon starvation and increase its tolerance toward rifampicin, a first-line drug effective against non-growing Mtb. Importantly, we show that Mtb can be eradicated during carbon starvation, in an OmamC-dependent manner, by inhibiting lipid metabolism with the lipase inhibitor tetrahydrolipstatin. This work casts new light into the survival processes of non-replicating, drug-tolerant Mtb by identifying new proteins involved in lipid metabolism required for the survival of dormant bacteria and exposing a potential vulnerability that could be exploited for antibiotic discovery.IMPORTANCETuberculosis is a global threat, with ~10 million yearly active cases. Many more people, however, live with "latent" infection, where Mycobacterium tuberculosis survives in a non-replicative form. When latent bacteria activate and regrow, they elicit immune responses and result in significant host damage. Replicating and non-growing bacilli can co-exist; however, non-growing bacteria are considerably less sensitive to antibiotics, thus complicating treatment by necessitating long treatment durations. Here, we sought to identify genes important for bacterial survival in this non-growing state using a carbon starvation model. We found that a previously uncharacterized gene, omamC, is involved in storing and utilizing fatty acids as bacteria transition between these two states. Importantly, inhibiting lipid metabolism using a lipase inhibitor eradicates non-growing bacteria. Thus, targeting lipid metabolism may be a viable strategy for treating the non-growing population in strategies to shorten treatment durations of tuberculosis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mycobacterium tuberculosis Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: MBio Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mycobacterium tuberculosis Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: MBio Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos